Filter
215
Text search:
Institut
Pasteur
Featured
Recommendations
20
New Publications
76
Language
Document type
No document type
112
Studies & Reports
39
Guidelines
30
Manuals
15
Strategic & Response Plan
7
Training Material
3
Fact sheets
3
Resource Platforms
2
Online Courses
2
Brochures
1
Situation Updates
1
Countries / Regions
Madagascar
24
Senegal
13
Congo, Democratic Republic of
11
Global
9
Guinea
8
Cameroon
8
Côte d’Ivoire / Ivory Coast
7
Central African Republic
7
Sierra Leone
6
Liberia
6
Nigeria
5
Burkina Faso
4
Mali
4
Guinea-Bissau
3
Niger
3
Latin America and the Carribbean
3
Western and Central Europe
3
Africa
3
Morocco
2
Ethiopia
2
Togo
2
Haiti
2
Germany
2
Chad
2
Kenya
2
Gambia
2
Rwanda
2
South Africa
2
Mozambique
2
Benin
2
Angola
2
West and Central Africa
2
Vietnam
2
France
2
Spain
2
Ghana
1
Zimbabwe
1
Philippines
1
South Sudan
1
Turkey
1
Tanzania
1
Mauritania
1
Malawi
1
Brazil
1
Cape Verde
1
East and Southern Africa
1
Eastern Europe
1
Laos
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
62
Clinical Guidelines
28
Pharmacy & Technologies
18
Public Health
10
Key Resources
5
Capacity Building
4
Women & Child Health
2
Toolboxes
Ebola & Marburg
31
Rapid Response
28
COVID-19
23
NTDs
17
Malaria
14
TB
11
Zika
8
2.0 Rapid Response
8
AMR
4
Cholera
3
Refugee
3
Planetary Health
3
Mental Health
2
Global Health Education
2
Pharmacy
2
Polio
1
HIV
1
Caregiver
1
Health Financing Toolbox
1
NCDs
1
Diese Broschüre möchte dazu beitragen, dass möglichst viele Menschen die Ergebnisse öffentlich finanzierter Forschung nutzen können.
Le panorama du paludisme a profondement changé durant la dernière décénnie. Les financements ont augmenté, les outils permettant de sauver des vies ont été mis en œuvre à plus grande échelle, la charge du paludisme a diminué et un nombre grandissant de pays envisagent son élimination.
C
...
Interim Recommendation published 19 September 2014. These recommendations reflect current understanding of Ebola virus disease (EVD) and are intended for national laboratory staff performing diagnostic testing to detect Ebola virus.
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e
...
- The goal of diagnostic testing for Ebola and Marburg virus diseases is to identify cases to provide timely and appropriate care and to stop disease transmission.
- All individuals meeting the case definition for Ebola or Marburg virus diseases should be tested.
- The recommended sample type
...
The following protocol has been designed to investigate the First Few X cases (FFX) and their close contacts. It is envisioned that the FFX 2019-nCoV investigation will be conducted across several countries or sites with geographical and demographical diversity. Using a standardized protocol such a
...
A Estratégia Conjunta Continental Africana para a COVID-19 é sustentada pela necessidade de limitar a transmissão, prevenir mortes e reduzir os danos associados. A participação das nações africanas em ensaios clínicos é um passo essencial para garantir que sejam gerados dados suficientes so
...
РУКОВОДСТВО ПО БИОЛОГИЧЕСКОЙ БЕЗОПАСНОСТИ ЛАБОРАТОРНЫХ ИССЛЕДОВАНИЙ ПРИ ТУБЕРКУЛЕЗЕ.
Pour l'achat de tests de diagnostic rapide du paludisme (TDR), plusieurs critères sont recommandés pour garantir la qualité et l'efficacité des tests. Ces critères se basent notamment sur la performance des tests, leur stabilité, leur facilité d'utilisation, leur coût et leur conformité aux
...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u
...
This is a case-ascertained prospective investigation of all identified health care contacts working in a health care facility in which a laboratory confirmed 2019-nCoV infected patient (see 2.2 Study population) receives care. Note that this study can be done in health care facilities at all 3 level
...
